Provided by Tiger Trade Technology Pte. Ltd.

SPYRE THERAPEUTICS INC

79.90
-0.9500-1.18%
Post-market: 79.900.00000.00%19:30 EDT
Volume:2.33M
Turnover:184.76M
Market Cap:7.05B
PE:-39.75
High:80.91
Open:79.58
Low:77.05
Close:80.85
52wk High:110.18
52wk Low:16.04
Shares:88.17M
Float Shares:80.98M
Volume Ratio:1.11
T/O Rate:2.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0100
EPS(LYR):-1.9755
ROE:-22.98%
ROA:-19.81%
PB:7.38
PE(LYR):-40.45

Loading ...

How Investors May Respond To Spyre Therapeutics (SYRE) Upsized Equity Raise After Positive SPY001 Phase 2 Data

Simply Wall St.
·
Apr 27

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Apr 21

Analysts Offer Insights on Healthcare Companies: Spyre Therapeutics (SYRE) and Revolution Medicines (RVMD)

TIPRANKS
·
Apr 20

Analysts Are Bullish on These Healthcare Stocks: Praxis Precision Medicines (PRAX), Spyre Therapeutics (SYRE)

TIPRANKS
·
Apr 18

Spyre Therapeutics closes follow-on offering, raises USD 463.5 million

Reuters
·
Apr 17

BUZZ-U.S. STOCKS ON THE MOVE-Nike, PNC Financia, OSI Systems

Reuters
·
Apr 16

BUZZ-Spyre Therapeutics gains after boosted $403 mln stock sale

Reuters
·
Apr 15

Spyre Therapeutics Prices Upsized $403 Million Share Offering

MT Newswires Live
·
Apr 15

BRIEF-Spyre Therapeutics Announces Pricing Of Upsized $403 Million Public Offering Of Common Stock

Reuters
·
Apr 15

Spyre Therapeutics Inc - Prices Public Offering of 6.5 Mln Shares at $62.00 per Share

THOMSON REUTERS
·
Apr 15

Spyre Therapeutics Announces Pricing of Upsized $403.0 Million Public Offering of Common Stock

THOMSON REUTERS
·
Apr 15

Assessing Spyre Therapeutics (SYRE) Valuation After Recent Share Price Momentum And Premium P/B Multiple

Simply Wall St.
·
Apr 15

Stock Track | Spyre Therapeutics Soars 6.99% in Pre-Market on Multiple Analyst Target Price Hikes

Stock Track
·
Apr 14

Spyre Therapeutics Inc : Wedbush Raises Target Price to $80 From $65

THOMSON REUTERS
·
Apr 14

Spyre Therapeutics, Inc. : Wells Fargo Raises Target Price to $90 From $50

THOMSON REUTERS
·
Apr 14

Spyre Therapeutics Inc : Deutsche Bank Raises Target Price to $88 From $55

THOMSON REUTERS
·
Apr 14

Spyre Therapeutics Inc : Jefferies Raises Target Price to $85 From $47

THOMSON REUTERS
·
Apr 14

BUZZ-Spyre drops on equity offering launch following inflammatory bowel drug trial

Reuters
·
Apr 14

BRIEF-Spyre Therapeutics Inc - Suspends And Terminates ATM Prospectus For At-The-Market Offering Effective April 13, 2026 - SEC Filing

Reuters
·
Apr 14

Spyre Therapeutics Launches $300 Million Stock Offering

MT Newswires Live
·
Apr 14